Qasem Al-Tashi

Publications

60+ publications · 5,900+ citations

Per Google Scholar: 7,000+ citations · h-index 24 · i10-index 39

Find My Publications in the Following Platforms

  1. Saad MB, Showkatian E, Verma V, Al-Tashi Q, Aminu M, Xu X, et al. (2025). “Causal AI-Based Clinical and Radiomic Analysis for Optimizing Patient Selection in Combined Immunotherapy and SABR in Early-Stage NSCLC: A Secondary Analysis of the Phase II I-SABR Trial.”

    Journal for Immunotherapy of Cancer, 13(10), e013074.

  2. Shami TM, Al-Tashi Q, Khodadadi N, Abdulkadir SJ, Ahmed A, Mirjalili S. (2025). “Dimension Selection: An Innovative Metaheuristic Strategy for Particle Swarm Optimization.”

    Cluster Computing, 28(6), 379.

  3. Deboever N, Al-Tashi Q, Eisenberg M, Saad MB, Antonoff MB, et al. (2025). “Machine-Learning Driven Strategies for Adapting Immunotherapy in Metastatic NSCLC.”

    Journal of the American College of Surgeons, 241(2), 107-116.

  4. Saad MB, Al-Tashi Q, Hong L, Verma V, Li W, Boiarsky D, Li S, et al. (2025). “Weighting Subgroup Identification Methods for Estimating Treatment Effect in NSCLC Patients Receiving Immune Checkpoint Inhibitors Alone or with Chemotherapy.”

    Nature Communications, 16(1), 6828.

  5. Alahdab F, Saad MB, Ahmed AI, Al-Tashi Q, Aminu M, Han Y, Moody JB, et al. (2024). “Development and Validation of a Machine Learning Model to Predict Myocardial Blood Flow and Clinical Outcomes from Patients' Electrocardiograms.”

    Cell Reports Medicine, 5(10).

  6. Saad MB, Al-Tashi Q, Hong L, Li W, Li S, Heymach JV, Lou Y, Vokes NI, et al. (2024). “I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage Non-Small Cell Lung Cancer.”

    Journal of Thoracic Oncology, 19(10), S40.

  7. Zubair M, Helmi B, Ullah F, Al-Tashi Q, Faheem M, Khan AA. (2024). “Enabling Prediction of Deep Learning Algorithms for Low-Dose CT Scan Image Denoising Models: A Systematic Literature Review.”

    IEEE Access, 12, 79025-79050.

  8. Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, ..., Al-Tashi Q, et al. (2023). “Predicting Benefit from Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer by CT-Based Ensemble Deep Learning: A Retrospective Study.”

    The Lancet Digital Health, 5(7), e404-e420.